{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:29:09Z","timestamp":1790749749925,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1173669"],"award-info":[{"award-number":["APP1173669"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The introduction of immune checkpoint inhibitors has demonstrated significant improvements in survival for subsets of cancer patients. However, they carry significant and sometimes life-threatening toxicities. Prompt prediction and monitoring of immune toxicities have the potential to maximise the benefits of immune checkpoint therapy. Herein, we develop a digital nanopillar SERS platform that achieves real-time single cytokine counting and enables dynamic tracking of immune toxicities in cancer patients receiving immune checkpoint inhibitor treatment - broader applications are anticipated in other disease indications. By analysing four prospective cytokine biomarkers that initiate inflammatory responses, the digital nanopillar SERS assay achieves both highly specific and highly sensitive cytokine detection down to attomolar level. Significantly, we report the capability of the assay to longitudinally monitor 10 melanoma patients during immune inhibitor blockade treatment. Here, we show that elevated cytokine concentrations predict for higher risk of developing severe immune toxicities in our pilot cohort of patients.<\/jats:p>","DOI":"10.1038\/s41467-021-21431-w","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T16:46:37Z","timestamp":1613753197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["A digital single-molecule nanopillar SERS platform for predicting and monitoring immune toxicities in immunotherapy"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3777-2245","authenticated-orcid":false,"given":"Junrong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9569-0478","authenticated-orcid":false,"given":"Alain","family":"Wuethrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8099-3863","authenticated-orcid":false,"given":"Abu A. I.","family":"Sina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-5111","authenticated-orcid":false,"given":"Han-Hao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3627-7397","authenticated-orcid":false,"given":"Yuling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5329-280X","authenticated-orcid":false,"given":"Andreas","family":"Behren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Mainwaring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5516-1280","authenticated-orcid":false,"given":"Matt","family":"Trau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"21431_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","volume":"161","author":"P Sharma","year":"2015","unstructured":"Sharma, P. & Allison, JamesP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161, 205\u2013214 (2015).","journal-title":"Cell"},{"key":"21431_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41577-020-0275-8","volume":"20","author":"P Sharma","year":"2020","unstructured":"Sharma, P. & Allison, J. P. Dissecting the mechanisms of immune checkpoint therapy. Nat. Rev. Immunol. 20, 75\u201376 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"21431_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56\u201361 (2015).","journal-title":"Science"},{"key":"21431_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","volume":"50","author":"P Darvin","year":"2018","unstructured":"Darvin, P., Toor, S. M., Sasidharan Nair, V. & Elkord, E. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp. Mol. Med. 50, 1\u201311 (2018).","journal-title":"Exp. Mol. Med."},{"key":"21431_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc.2016.36","volume":"16","author":"SL Topalian","year":"2016","unstructured":"Topalian, S. L., Taube, J. M., Anders, R. A. & Pardoll, D. M. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat. Rev. Cancer 16, 275\u2013287 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"21431_CR6","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350\u20131355 (2018).","journal-title":"Science"},{"key":"21431_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow, M. A., Sidlow, R. & Hellmann, M. D. Immune-related adverse events associated with immune checkpoint blockade. N. Engl. J. Med. 378, 158\u2013168 (2018).","journal-title":"N. Engl. J. Med."},{"key":"21431_CR8","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1158\/1078-0432.CCR-15-1136","volume":"22","author":"M Freeman-Keller","year":"2016","unstructured":"Freeman-Keller, M. et al. Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes. Clin. Cancer Res. 22, 886\u2013894 (2016).","journal-title":"Clin. Cancer Res."},{"key":"21431_CR9","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1158\/1078-0432.CCR-18-2795","volume":"25","author":"SY Lim","year":"2019","unstructured":"Lim, S. Y. et al. Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-pd-1-based immunotherapy. Clin. Cancer Res. 25, 1557\u20131563 (2019).","journal-title":"Clin. Cancer Res."},{"key":"21431_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrneurol.2017.144","volume":"13","author":"LM Yshii","year":"2017","unstructured":"Yshii, L. M., Hohlfeld, R. & Liblau, R. S. Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives. Nat. Rev. Neurol. 13, 755\u2013763 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"21431_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41416-018-0155-1","volume":"120","author":"S Khan","year":"2019","unstructured":"Khan, S. et al. Immune dysregulation in cancer patients developing immune-related adverse events. Br. J. Cancer 120, 63\u201368 (2019).","journal-title":"Br. J. Cancer"},{"key":"21431_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41584-018-0074-9","volume":"14","author":"LH Calabrese","year":"2018","unstructured":"Calabrese, L. H., Calabrese, C. & Cappelli, L. C. Rheumatic immune-related adverse events from cancer immunotherapy. Nat. Rev. Rheumatol. 14, 569\u2013579 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"21431_CR13","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1158\/1078-0432.CCR-18-3858","volume":"25","author":"DB Johnson","year":"2019","unstructured":"Johnson, D. B. & Balko, J. M. Biomarkers for immunotherapy toxicity: are cytokines the answer? Clin. Cancer Res. 25, 1452\u20131454 (2019).","journal-title":"Clin. Cancer Res."},{"key":"21431_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","volume":"120","author":"P Berraondo","year":"2019","unstructured":"Berraondo, P. et al. Cytokines in clinical cancer immunotherapy. Br. J. Cancer 120, 6\u201315 (2019).","journal-title":"Br. J. Cancer"},{"key":"21431_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ccr.2013.02.019","volume":"23","author":"F Bono","year":"2013","unstructured":"Bono, F. et al. Inhibition of tumor angiogenesis and growth by a small-molecule multi-fgf receptor blocker with allosteric properties. Cancer Cell 23, 477\u2013488 (2013).","journal-title":"Cancer Cell"},{"key":"21431_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cca.2006.06.033","volume":"375","author":"CJ Malemud","year":"2007","unstructured":"Malemud, C. J. Growth hormone, vegf and fgf: Involvement in rheumatoid arthritis. Clin. Chim. Acta 375, 10\u201319 (2007).","journal-title":"Clin. Chim. Acta"},{"key":"21431_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2353\/ajpath.2006.050479","volume":"168","author":"SI Zittermann","year":"2006","unstructured":"Zittermann, S. I. & Issekutz, A. C. Basic fibroblast growth factor (bfgf, fgf-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am. J. Clin. Pathol. 168, 835\u2013846 (2006).","journal-title":"Am. J. Clin. Pathol."},{"key":"21431_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrd2792","volume":"8","author":"A Beenken","year":"2009","unstructured":"Beenken, A. & Mohammadi, M. The fgf family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8, 235\u2013253 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"21431_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40425-019-0582-4","volume":"7","author":"O Honjo","year":"2019","unstructured":"Honjo, O. et al. Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report. J. Immunother. Cancer 7, 97 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"21431_CR20","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3389\/fimmu.2019.01265","volume":"10","author":"N Lotfi","year":"2019","unstructured":"Lotfi, N. et al. Roles of gm-csf in the pathogenesis of autoimmune diseases: an update. Front. Immunol. 10, 1265 (2019).","journal-title":"Front. Immunol."},{"key":"21431_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1124\/mi.10.5.3","volume":"10","author":"BA Jones","year":"2010","unstructured":"Jones, B. A., Beamer, M. & Ahmed, S. Fractalkine\/cx3cl1: a potential new target for inflammatory diseases. Mol. Interv. 10, 263\u2013270 (2010).","journal-title":"Mol. Interv."},{"key":"21431_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ni.1713","volume":"10","author":"JS Bezbradica","year":"2009","unstructured":"Bezbradica, J. S. & Medzhitov, R. Integration of cytokine and heterologous receptor signaling pathways. Nat. Immunol. 10, 333\u2013339 (2009).","journal-title":"Nat. Immunol."},{"key":"21431_CR23","doi-asserted-by":"crossref","unstructured":"Li, J. et al. The growing impact of micro\/nanomaterial-based systems in precision oncology: translating \u201cmultiomics\u201d technologies. Adv. Funct. Mater. 30, 1909306, (2020).","DOI":"10.1002\/adfm.201909306"},{"key":"21431_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nbt.1641","volume":"28","author":"DM Rissin","year":"2010","unstructured":"Rissin, D. M. et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat. Biotechnol. 28, 595\u2013599 (2010).","journal-title":"Nat. Biotechnol."},{"key":"21431_CR25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41551-019-0356-9","volume":"3","author":"P Zhang","year":"2019","unstructured":"Zhang, P. et al. Ultrasensitive detection of circulating exosomes with a 3d-nanopatterned microfluidic chip. Nat. Biomed. Eng. 3, 438\u2013451 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"21431_CR26","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1021\/acs.nanolett.8b01184","volume":"18","author":"C Liu","year":"2018","unstructured":"Liu, C. et al. Single-exosome-counting immunoassays for cancer diagnostics. Nano Lett. 18, 4226\u20134232 (2018).","journal-title":"Nano Lett."},{"key":"21431_CR27","doi-asserted-by":"publisher","first-page":"18132","DOI":"10.1021\/jacs.8b11185","volume":"140","author":"X Wang","year":"2018","unstructured":"Wang, X., Cohen, L., Wang, J. & Walt, D. R. Competitive immunoassays for the detection of small molecules using single molecule arrays. J. Am. Chem. Soc. 140, 18132\u201318139 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"21431_CR28","doi-asserted-by":"publisher","first-page":"10489","DOI":"10.1021\/acs.chemrev.5b00265","volume":"115","author":"LA Lane","year":"2015","unstructured":"Lane, L. A., Qian, X. & Nie, S. SERS nanoparticles in medicine: from label-free detection to spectroscopic tagging. Chem. Rev. 115, 10489\u201310529 (2015).","journal-title":"Chem. Rev."},{"key":"21431_CR29","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1021\/cr300120g","volume":"113","author":"Y Wang","year":"2013","unstructured":"Wang, Y., Yan, B. & Chen, L. Sers tags: novel optical nanoprobes for bioanalysis. Chem. Rev. 113, 1391\u20131428 (2013).","journal-title":"Chem. Rev."},{"key":"21431_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1021\/acsnano.9b04224","volume":"14","author":"J Langer","year":"2020","unstructured":"Langer, J. et al. Present and future of surface-enhanced raman scattering. ACS Nano 14, 28\u2013117 (2020).","journal-title":"ACS Nano"},{"key":"21431_CR31","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1021\/acssensors.8b00566","volume":"3","author":"JH Granger","year":"2018","unstructured":"Granger, J. H. & Porter, M. D. The case for human serum as a highly preferable sample matrix for detection of anthrax toxins. ACS Sens. 3, 2303\u20132310 (2018).","journal-title":"ACS Sens."},{"key":"21431_CR32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.talanta.2019.05.080","volume":"203","author":"K Toma","year":"2019","unstructured":"Toma, K. et al. Repeated immunosensing by a dithiobis(succinimidyl propionate)-modified saw device. Talanta 203, 274\u2013279 (2019).","journal-title":"Talanta"},{"key":"21431_CR33","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/S0021-9258(18)32943-0","volume":"258","author":"PA Cuypers","year":"1983","unstructured":"Cuypers, P. A. et al. The adsorption of prothrombin to phosphatidylserine multilayers quantitated by ellipsometry. J. Biol. Chem. 258, 2426\u20132431 (1983).","journal-title":"J. Biol. Chem."},{"key":"21431_CR34","doi-asserted-by":"publisher","first-page":"146269","DOI":"10.1016\/j.apsusc.2020.146269","volume":"518","author":"K Gajos","year":"2020","unstructured":"Gajos, K., Szafraniec, K., Petrou, P. & Budkowski, A. Surface density dependent orientation and immunological recognition of antibody on silicon: Tof-sims and surface analysis of two covalent immobilization methods. Appl. Surf. Sci. 518, 146269 (2020).","journal-title":"Appl. Surf. Sci."},{"key":"21431_CR35","doi-asserted-by":"publisher","first-page":"1904689","DOI":"10.1002\/smll.201904689","volume":"15","author":"J Li","year":"2019","unstructured":"Li, J., Koo, K. M., Wang, Y. & Trau, M. Native microrna targets trigger self-assembly of nanozyme-patterned hollowed nanocuboids with optimal interparticle gaps for plasmonic-activated cancer detection. Small 15, 1904689 (2019).","journal-title":"Small"},{"key":"21431_CR36","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1021\/jp8101817","volume":"113","author":"M Rycenga","year":"2009","unstructured":"Rycenga, M. et al. Surface-enhanced raman scattering: comparison of three different molecules on single-crystal nanocubes and nanospheres of silver. J. Phys. Chem. A 113, 3932\u20133939 (2009).","journal-title":"J. Phys. Chem. A"},{"key":"21431_CR37","doi-asserted-by":"publisher","first-page":"9934","DOI":"10.1039\/C4TC02004A","volume":"2","author":"J-M Li","year":"2014","unstructured":"Li, J.-M., Yang, Y. & Qin, D. Hollow nanocubes made of ag\u2013au alloys for SERS detection with sensitivity of 10\u22128 m for melamine. J. Mater. Chem. C 2, 9934\u20139940 (2014).","journal-title":"J. Mater. Chem. C"},{"key":"21431_CR38","doi-asserted-by":"publisher","first-page":"21120","DOI":"10.1039\/C4CP05073H","volume":"17","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y., Walkenfort, B., Yoon, J. H., Schlucker, S. & Xie, W. Gold and silver nanoparticle monomers are non-sers-active: a negative experimental study with silica-encapsulated raman-reporter-coated metal colloids. Phys. Chem. Chem. Phys. 17, 21120\u201321126 (2015).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"21431_CR39","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1021\/acs.analchem.9b02872","volume":"91","author":"MJ Mickert","year":"2019","unstructured":"Mickert, M. J. et al. Measurement of sub-femtomolar concentrations of prostate-specific antigen through single-molecule counting with an upconversion-linked immunosorbent assay. Anal. Chem. 91, 9435\u20139441 (2019).","journal-title":"Anal. Chem."},{"key":"21431_CR40","doi-asserted-by":"publisher","first-page":"32526","DOI":"10.1021\/acsami.8b10112","volume":"10","author":"J Li","year":"2018","unstructured":"Li, J. et al. Facile one-pot synthesis of nanodot-decorated gold\u2013silver alloy nanoboxes for single-particle surface-enhanced raman scattering activity. ACS Appl. Mater. Interfaces 10, 32526\u201332535 (2018).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"21431_CR41","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1039\/C7CS00158D","volume":"46","author":"J Reguera","year":"2017","unstructured":"Reguera, J., Langer, J., Jimenez de Aberasturi, D. & Liz-Marzan, L. M. Anisotropic metal nanoparticles for surface enhanced raman scattering. Chem. Soc. Rev. 46, 3866\u20133885 (2017).","journal-title":"Chem. Soc. Rev."},{"key":"21431_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","volume":"556","author":"A-C Wendeln","year":"2018","unstructured":"Wendeln, A.-C. et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature 556, 332\u2013338 (2018).","journal-title":"Nature"},{"key":"21431_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Paradoxical effects of obesity on t cell function during tumor progression and pd-1 checkpoint blockade. Nat. Med. 25, 141\u2013151 (2019).","journal-title":"Nat. Med."},{"key":"21431_CR44","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1002\/smll.201000418","volume":"6","author":"DK Chatterjee","year":"2010","unstructured":"Chatterjee, D. K., Gnanasammandhan, M. K. & Zhang, Y. Small upconverting fluorescent nanoparticles for biomedical applications. Small 6, 2781\u20132795 (2010).","journal-title":"Small"},{"key":"21431_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.aca.2017.12.010","volume":"1019","author":"SA Pidenko","year":"2018","unstructured":"Pidenko, S. A. et al. Microstructured optical fiber-based luminescent biosensing: is there any light at the end of the tunnel? - a review. Anal. Chim. Acta 1019, 14\u201324 (2018).","journal-title":"Anal. Chim. Acta"},{"key":"21431_CR46","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1021\/cm504251h","volume":"27","author":"B Mir-Simon","year":"2015","unstructured":"Mir-Simon, B., Reche-Perez, I., Guerrini, L., Pazos-Perez, N. & Alvarez-Puebla, R. A. Universal one-pot and scalable synthesis of sers encoded nanoparticles. Chem. Mater. 27, 950\u2013958 (2015).","journal-title":"Chem. Mater."},{"key":"21431_CR47","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/cphc.200900119","volume":"10","author":"S Schl\u00fccker","year":"2009","unstructured":"Schl\u00fccker, S. SERS microscopy: nanoparticle probes and biomedical applications. ChemPhysChem 10, 1344\u20131354 (2009).","journal-title":"ChemPhysChem"},{"key":"21431_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03725-8","volume":"9","author":"SC-H Tsao","year":"2018","unstructured":"Tsao, S. C.-H. et al. Characterising the phenotypic evolution of circulating tumour cells during treatment. Nat. Commun. 9, 1482 (2018).","journal-title":"Nat. Commun."},{"key":"21431_CR49","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1021\/nl070157q","volume":"7","author":"JM McLellan","year":"2007","unstructured":"McLellan, J. M., Li, Z.-Y., Siekkinen, A. R. & Xia, Y. The sers activity of a supported ag nanocube strongly depends on its orientation relative to laser polarization. Nano Lett. 7, 1013\u20131017 (2007).","journal-title":"Nano Lett."},{"key":"21431_CR50","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1073\/pnas.1814110116","volume":"116","author":"V Yelleswarapu","year":"2019","unstructured":"Yelleswarapu, V. et al. Mobile platform for rapid sub\u2013picogram-per-milliliter, multiplexed, digital droplet detection of proteins. Proc. Natl Acad. Sci. USA 116, 4489\u20134495 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"21431_CR51","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1039\/C5AN01238D","volume":"140","author":"D Wu","year":"2015","unstructured":"Wu, D., Milutinovic, M. D. & Walt, D. R. Single molecule array (simoa) assay with optimal antibody pairs for cytokine detection in human serum samples. Analyst 140, 6277\u20136282 (2015).","journal-title":"Analyst"},{"key":"21431_CR52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3322\/caac.21596","volume":"70","author":"LB Kennedy","year":"2020","unstructured":"Kennedy, L. B. & Salama, A. K. S. A review of cancer immunotherapy toxicity. CA Cancer J. Clin. 70, 86\u2013104 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"21431_CR53","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13229-017-0176-2","volume":"8","author":"A Masi","year":"2017","unstructured":"Masi, A. et al. Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder. Mol. Austism 8, 63 (2017).","journal-title":"Mol. Austism"},{"key":"21431_CR54","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in wuhan, china. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21431-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21431-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21431-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T10:37:52Z","timestamp":1669977472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21431-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["21431"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-21431-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"27 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1087"}}